Kenton Oncology, Incorporated
Kenton, Ohio 43326
0 studies enrolling now · 15 studies all time
What they study most
Anorexia, Breast Cancer, Cachexia, Esophageal Cancer, Fatigue, Hot Flashes, Lung Cancer, Lymphoma, Neurotoxicity, Osteoporosis, Pain, Pancreatic Cancer
Studies at this site
- Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma — Completed
- Quality of Life in Postmenopausal Women Who Are Receiving Either Exemestane or Anastrozole With or Without Celecoxib for Stage I, Stage II, or Stage IIIA Primary Breast Cancer — Completed
- S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer — Completed
- Gefitinib With or Without Carboplatin and Paclitaxel in Treating Older Patients With Unresectable or Metastatic Non-Small Cell Lung Cancer — Completed
- Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer — Completed
- Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer — Completed
- Gefitinib in Treating Patients With Locally Advanced Esophageal Cancer — Completed
- Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05) — Completed
- Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer — Completed
- EGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast Cancer — Completed
- Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer — Completed
- Lidocaine Patch in Treating Cancer Patients With Neuropathic Pain After Surgery — Completed
- S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer — Completed
- S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer — Completed
- ABI-007 (Nab-Paclitaxel) and Gemcitabine in Treating Women With Metastatic Breast Cancer — Completed